Guotai Junan: From policy expectation to focusing on performance, the marginal improvement of mass goods, Guotai Junan said, from policy expectation to focusing on performance, the marginal improvement of mass goods, stable drinks, marginal decline of alcohol, configuration: mass goods > beer & drinks > liquor, first grow before value, first choose snacks, certain preferred condiments, drinks and beer, and gradually lay out liquor: under low expectation, the layout is oversold and the valuation target is low, which is steady. Popular products: 1) Snacks and some condiments are preferred. 2) beer and drinks. 3) tobacco.Australia's S&P/ASX200 index opened down 12.60 points, or 0.15%, at 8380.4 points on Wednesday, December 11th.On the morning of December 9, Leo, Party Secretary and Chairman of Shanghai Electric Group, went to Seoul, South Korea, and held talks with Zhao Xianjun, President of Xiaoxing Group. The two sides had in-depth exchanges on joint ventures and cooperation in the field of new energy. During the talks, the two sides also discussed the cooperation potential in the fields of hydrogen energy and power grid equipment, sought cooperation opportunities in technology research and development, project investment and market development, and jointly explored cooperative development models in the field of new energy to meet the challenges brought by global energy transformation.
Guotai Junan: From policy expectation to focusing on performance, the marginal improvement of mass goods, Guotai Junan said, from policy expectation to focusing on performance, the marginal improvement of mass goods, stable drinks, marginal decline of alcohol, configuration: mass goods > beer & drinks > liquor, first grow before value, first choose snacks, certain preferred condiments, drinks and beer, and gradually lay out liquor: under low expectation, the layout is oversold and the valuation target is low, which is steady. Popular products: 1) Snacks and some condiments are preferred. 2) beer and drinks. 3) tobacco.CITIC Securities: The logic of "grabbing exports" is expected to support the short-term performance of China's exports. According to the CITIC Securities Research Report, in November, China's exports maintained a certain growth rate, exports to emerging markets maintained a high growth rate, and exports of mechanical and electrical products performed brilliantly. In the short term, both CCFI index and SCFI index are on the rise, and the logic of "grabbing exports" is expected to support the short-term performance of China's exports. In the long run, if the United States imposes tariffs on China, China's export performance may be dragged down. However, based on the analysis of the import share structure of the United States, the European Union, Vietnam, Mexico and other economies, we can see that the current pattern of China's trade diversification has improved compared with the last round of Sino-US trade friction, and the trade between emerging markets and China has become closer and closer. The imposition of tariffs by the United States on China may affect the bilateral trade between China and the United States more, and domestic enterprises going to sea and re-exporting trade may still be effective ways to hedge the impact of US tariffs on China.Guotai Junan's annual strategy for innovative drugs in 2025: innovative pharmaceutical companies have accelerated into the harvest period, and the valuation has been at a historical low in the past five years. Guotai Junan said that the centralized purchasing policy has become stable, mature and normalized, and the marginal impact has weakened. Innovative drugs have gained policy inclination in the medical insurance negotiation. In the past two years, the policy has continued to promote pharmaceutical innovation, and the top-level design and local supporting chain support the development of innovative drugs. Commercial insurance is expected to bring new growth momentum to China's pharmaceutical market, and the overall industry trend is upward. At present, the trend of innovative drug industry is improving, the supply continues to accelerate, and a number of domestic innovative drugs are approved soon, which is expected to drive a new round of heavy volume. At the same time, the commercialization has achieved remarkable results and has occupied a dominant position in some sub-sectors. Pharma's performance continued to differentiate, and innovative drugs and just-needed drugs performed well. Biotech commercialization continues to increase, per capita yield continues to increase, the node of turning losses is approaching, and innovation ushers in the harvest period. Horizontal comparison: compared with overseas peers, the overall valuation of domestic innovative pharmaceutical companies is in a historically low range; Vertical comparison: the valuation of SW- pharmaceutical biology and SW- chemical preparations is at a historical low in the past five years, and it is expected that the valuation of subsequent sectors will pick up.
General Motors (GM): The unmanned business Cruise and GM Technical team will be merged, and the plan is expected to be completed in the first half of 2025. According to the priority of GM's capital allocation, GM will no longer fund Cruise's self-driving taxi development business.US Treasury Department: US Treasury Secretary Yellen expressed appreciation for the close communication between the Ministry of Economic Affairs of Korea and the United States after the recent events in South Korea.The negotiation between Myriad and United Health Insurance may be extended to the beginning of 2025, and the negotiation between Myriad Genetics and UnitedHealthcare on the genetic test of Myriad may continue until the beginning of 2025. Myriad reiterated its estimate of the financial impact of the United Health Insurance Company's updated medical policy in 2024.
Strategy guide 12-13
Strategy guide 12-13
Strategy guide 12-13